Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
698 studies found for:    "Venous Thrombosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Venous Thrombosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Outcome of Percutaneous Mechanical Thrombectomy to Treat Acute Deep Venous Thrombosis
Condition: Deep Venous Thrombosis
Intervention: Procedure: Percutaneous mechanical thrombectomy
2 Recruiting The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)
Condition: Cerebral Venous Thrombosis
Intervention: Other: ELISA Test
3 Completed Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs
Condition: Deep Venous Thrombosis
Interventions: Drug: Idrabiotaparinux sodium;   Drug: Idraparinux sodium;   Drug: Avidin;   Drug: Placebo (for Avidin)
4 Completed Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis
Condition: Deep Venous Thrombosis
Intervention:
5 Withdrawn Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac Surgery
Condition: Asymptotic Venous Thrombosis
Intervention: Drug: Enoxaparin
6 Completed Thrombin Generation and Thrombus Degradation in Cerebral Venous Thrombosis : Clinical and Radiological Correlations
Condition: Cerebral Venous Thrombosis
Intervention:
7 Withdrawn Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis
Condition: Venous Thrombosis
Intervention: Drug: 99mTc-rBitistatin
8 Completed Oral Rivaroxaban in Children With Venous Thrombosis
Condition: Venous Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
9 Completed Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication
Condition: Venous Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
10 Enrolling by invitation Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
Condition: Venous Thrombosis
Interventions: Device: a manual spiral thrombus broken suction device;   Procedure: catheter-directed thrombolysis;   Drug: low-molecular-weight heparin calcium;   Drug: urokinase
11 Completed Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities
Condition: Deep Venous Thrombosis
Interventions: Drug: unfractionated heparin;   Drug: Tinzaparin (Leo)
12 Recruiting Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.
Condition: Deep Venous Thrombosis
Interventions: Drug: Rivaroxaban;   Drug: Warfarin
13 Recruiting Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)
Condition: Deep Venous Thrombosis
Interventions: Drug: GMI-1271;   Drug: Enoxaparin Sodium (Lovenox®)
14 Withdrawn Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care Patients
Condition: Lower Extremity Deep Venous Thrombosis
Interventions: Drug: heparin;   Drug: enoxaparin
15 Completed Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)
Condition: Venous Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
16 Completed Optimal Duration of Anticoagulation in Deep Venous Thrombosis
Conditions: Deep Vein Thrombosis of Lower Limb;   Lower Extremity Deep Venous Thrombosis Recurrent
Intervention: Drug: Sodium warfarin
17 Completed Simplification of the Diagnosis of Deep Vein Thrombosis
Condition: Deep Venous Thrombosis
Intervention: Other: Extensive search for isolated calf DVT
18 Recruiting Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion
Condition: Venous Thrombosis
Intervention:
19 Completed
Has Results
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study
Condition: Venous Thrombosis
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Enoxaparin followed by VKA
20 Completed
Has Results
Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Device: DVT-3000;   Device: SCD Express

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.